Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat-containing protein 73 (WDR73) is a cytoplasmic and nuclear protein characterized by six WD40 repeats forming a six-bladed propeller structure, typically mediating protein-protein interactions. It acts as a scaffolding protein important for the assembly of the Integrator complex RNA endonuclease module by physically associating with members such as INTS9 and INTS11. WDR73 is essential for the regulation and organization of the microtubule network, ensuring proper cell cycle progression, cell survival, and possibly RNA processing and transcriptional control. Loss-of-function mutations in WDR73 cause Galloway-Mowat syndrome, a rare disorder involving both the central nervous system (especially cerebellar atrophy and microcephaly) and the kidney (nephrotic syndrome and focal segmental glomerulosclerosis), likely due to defects in cell survival and cytoskeletal organization in neurons and podocytes. WDR73 is not recognized as a classical therapeutic target (such as a receptor, enzyme, transporter, or ion channel), nor do known drugs directly target it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat-containing protein 73 (WDR73).